2013
DOI: 10.1186/1750-1172-8-194
|View full text |Cite
|
Sign up to set email alerts
|

Genotype-dependency of butyrate efficacy in children with congenital chloride diarrhea

Abstract: BackgroundCongenital chloride diarrhea (CLD) is an autosomal recessive disorder characterized by life-long, severe diarrhea with intestinal Cl- malabsorption. It results from a reduced activity of the down regulated in adenoma exchanger (DRA), due to mutations in the solute carrier family 26, member 3 (SLC26A3) gene. Currently available therapies are not able to limit the severity of diarrhea in CLD. Conflicting results have been reported on the therapeutic efficacy of oral butyrate.MethodsWe investigated the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
25
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
5
3
1

Relationship

1
8

Authors

Journals

citations
Cited by 33 publications
(25 citation statements)
references
References 29 publications
0
25
0
Order By: Relevance
“…These can differently affect the encoded myosin Vb protein and, conceivably, brush border protein localization and drug response. A genotype-dependency for the therapeutic efficacy of butyrate was recently reported in CCD patients [ 63 ]. Future genotype–phenotype correlation studies may shed light on and help predicting treatment responses.…”
Section: Discussion and Future Perspectivesmentioning
confidence: 99%
“…These can differently affect the encoded myosin Vb protein and, conceivably, brush border protein localization and drug response. A genotype-dependency for the therapeutic efficacy of butyrate was recently reported in CCD patients [ 63 ]. Future genotype–phenotype correlation studies may shed light on and help predicting treatment responses.…”
Section: Discussion and Future Perspectivesmentioning
confidence: 99%
“…Adequate butyrate can suppress over-growth of pathogenic bacteria and reinforce the intestinal defense barrier. ( 36 38 ) This protection against gastrointestinal diseases might be mediated by modulating transepithelial ion transport, ( 39 ) reducing oxidative damage to DNA, and apoptosis induction in DNA-damaged cells. ( 40 , 41 ) Butyrate is primarily supplied by butyrate-producing bacteria in vivo , specifically the Clostridium genera of Firmicutes .…”
Section: Discussionmentioning
confidence: 99%
“…Others tried butyrate with promising results in some populations. [4951] None of our patients was tried on any of them due to unavailability in our center.…”
Section: Discussionmentioning
confidence: 99%